Identification of phosphoproteins in kidney tissues from patients with autosomal dominant polycystic kidney disease

Proteomics - Clinical Applications

Volumn 2, Issue 7-8, 2008, Pages 1153-1166

  Liu, Yawei ^a   Dai, Bing ^a   Mei, Changlin ^a   Zhang, Yan ^a   Xiong, Xishan ^a   Sandford, Richard ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

2 DE; Autosomal dominant polycystic kidney disease; Phosphorylation

Indexed keywords

ANTIOXIDANT; CHAPERONE; CYTOSKELETON PROTEIN; LIPOCORTIN 2; MITOCHONDRIAL ENZYME; PHOSPHOPROTEIN; TRANSCRIPTION FACTOR; TROPOMYOSIN;

ADULT; AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; CASE REPORT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; KIDNEY PARENCHYMA; KIDNEY POLYCYSTIC DISEASE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

EID: 50849120066     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780172     Document Type: Article

References (50)

1. Wilson, P. D., Polycystic kidney disease. N. Engl. J. Med. 2004, 350, 151-164.
2. The European Polycystic Kidney Disease Consortium, The polycystic kidney disease 1 gene encodes a 14kb transcript and lies within a duplicated region on chromosme 16. Cell 1994, 77, 881-894.
3. The American PKD1 Consortium. Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease gene (PKD1) predicts the presence of a leucine-rich repeat. Hum. Mol. Genet. 1995, 4, 575-582.
4. The International Polycystic Kidney Disease Consortium, Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995, 81, 289-298.
5. Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L. et al., PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996, 272, 1339-1342.
6. Roitbak, T., Ward, C. J., Harris, P. C., Bacallao, R., A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol. Biol. Cell 2004, 15, 1334-1346.
7. Li, H. P., Geng, L., Burrow, C. R., Wilson, P. D., Identification of phosphorylation sites in the PKD1-encoded protein C-terminal domain. Biochem. Biophys. Res. Commun. 1999, 259, 356-363.
8. Li, X., Burrow, C. R., Polgar, K., Hyink, D. P. et al., Protein kinase X (PRKX) can rescue the effects of polycystic kidney disease-1 gene (PKD1) deficiency. Biochim. Biophys. Acta 2008, 1782, 1-9.
9. Cai, Y., Anyatonwu, G., Okuhara, D., Lee, K. B. et al., Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J. Biol. Chem. 2004, 279, 19987-19995.
10. Sweeney, W. E., Jr., Avner, E. D., Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am. J. Physiol. 1998, 275, F387-394.
11. Nagao, S., Yamaguchi, T., Kusaka, M., Maser, R. L. et al., Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney Int. 2003, 63, 427-437.
12. Yamaguchi, T., Nagao, S., Wallace, D. P., Belibi, F. A. et al., Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosamal-dominant polycystic kidneys. Kidney Int 2003, 63, 1983-1994.
13. Yamaguchi, T., Wallace, D. P., Magenheimer, B. S., Hempson, S. J. et al., Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J. Biol. Chem. 2004, 279, 40419-40430.
14. Wahl, P. R., Le, Hir, M., Vogetseder, A., Arcaro, A. et al., Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease. Nephrology 2007, 12, 357-363.
15. Boca, M., Distefano, G., Qian, F., Bhunia, A. K. et al., Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway. J. Am. Soc. Nephrol. 2006, 17, 637-647.
16. Marcantonio, M., Trost, M., Courcelles, M., Desjardins, M. et al., Combined enzymatic and data mining approaches for comprehensive phosphoproteome analyses; application to cell signaling events of interferon-stimulated macrophages. Mol. Cell. Proteomics 2008, 7, 645-660.
17. Kersey, P. J., Duarte, J., Williams, A., Karavidopoulou, Y. et al., The International Protein Index: An integrated database for proteomics experiments. Proteomics 2004, 4, 1985-1988.
18. Eng, J. K., Mecommck, A. L., Yates, J. R., Correlating tandem mass spectral data of peptides to sequences in protein database. J. Am. Soc. Mass Spectrom. 1994, 5, 976-989.
19. Washburn, M. P., Wolters, D., Yates, J. R., 3rd., Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
20. Reinders, J., Sickmann, A., State-of-the-art in phosphoproteomics. Proteomics 2005, 5, 4052-4061.
21. Mann, M., Ong, S. E., Grønborg, M., Steen., H. et al., Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 2002, 20, 261-268.
22. Girault, S., Chassaing, G., Blais, J. C., Brunot, A., Bolbach, G., Coupling of MALDI-TOF mass analysis to the separation of biotinylated peptides by magnetic streptavidin beads. Anal. Chem. 1996, 68, 2122-2126.
23. Adamczyk, M., Gebler, J. C., Wu, J., Selective analysis of phosphopeptides within a protein mixture by chemical modification, reversible biotinylation and mass spectrometry. Rapid Commun. Mass Spectrom. 2001, 15, 1481-1488.
24. Knight, Z. A., Schilling, B., Row, R. H., Kenski, D. M. et al., Phosphospecific proteolysis for mapping sites of protein phosphorylation. Nat. Biotechnol. 2003, 21, 1047-1054.
25. Li, H., Xiao, Y. B., Gao, Y. Q., Yang, T. D., Comparative proteomics analysis of differentially expressed phosphoproteins in adult rat ventricular myocytes subjected to diazoxide preconditioning. Drug Metab. Drug Interact. 2006, 21, 245-58.
26. Yan, G., Li, L., Tao, Y., Liu, S. et al., Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology. Proteomics 2006, 6, 1810-1821.
27. Sami, I., Eliandre, O., Montserrat, P., Adela, G., Towards the identification of late-embryogenic abundant phosphoproteome in Arabidopsis by 2-DE and MS. Proteomics 2006, 6, S175-S185.
28. Kang, T. H., Bae, K. H., Yu, M. J., Kim, W. K. et al., Phosphoproteomic analysis of neuronal cell death by glutamate-induced oxidative stress. Proteomics 2007, 7, 2624-2635.
29. Puente, L. G., Carrière, J. F., Kelly, J. F., Megeney, L. A., Comparative analysis of phosphoprotein-enriched myocyte proteomes reveals widespread alterations during differentiation. FEBS Lett. 2004, 574, 138-144
30. Metodiev, M. V., Timanova, A., Stone, D. E., Differential phosphoproteome profiling by affinity capture and tandem matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 2004, 4, 1433-1438.
31. Makrantoni, V., Antrobus, R., Botting, C. H., Coote, P. J., Rapid enrichment and analysis of yeast phosphoproteins using affinity chromatography, 2D-PAGE and peptide mass fingerprinting. Yeast 2005, 22, 401-414.
32. Kaspareit-Rittinghausen, J., Deerberg, F., Rapp, K. G., Wcislo, A., A new rat model for polycystic kidney disease of humans. Transplant. Proc. 1990, 22, 2582-2583.
33. Schäfer, K., Gretz, N., Bader, M., Oberbäumer, I. et al., Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease. Kidney Int. 1994, 46, 134-152.
34. Hubaishy, I., Jones, P. G., Bjorge, J., Bellagamba, C. et al., Modulation of annexin II tetramer by tyrosine phosphorylation. Biochemistry 1995, 34, 14527-14534.
35. Chiang, Y., Rizzino, A., Sibenaller, Z. A., Wold, M. S., Vishwanatha, J. K., Specific dawn-regulation of annexin II expression in human cells interferes with cell proliferation. Mol. Cell. Biochem. 1999, 199, 139-147.
36. Brambilla, R., Zippel, R., Sturani, E., Morello, L. et al., Characterization of the tyrosine phosphorylation of calpactin I (annexin II) induced by platelet derived growth factor. Biochem. J. 1991, 278, 447-452.
37. Pei, Y., Molecular genetics of autosomal dominant polycystic kidney disease. Clin. Invest. Med. 2003, 26, 252-258.
38. Delcommenne, M., Tan, C., Gray, V., Rue, L. et al., Phosphoinositide-3-OH kinase dependent regulation of glycogen synthase kinase 3 and protein kinaseB/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. USA 1998, 95, 11211-11216.
39. Persad, S., Attwell, S., Gray, V., Mawji, N. et al., Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J. Biol. Chem. 2001, 276, 27462-27469.
40. Oloumi, A., McPhee, T., Dedhar, S., Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim. Biophys. Acta 2004, 1691, 1-15.
41. Wilson, P. D., Geng, L., Li, X., Burrow, C. R., The PKD1 gene product, "polycystin-1, is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia. Lab. Invest. 1999, 79, 1311-1323.
42. Ku, N. O., Zhou, X., Toivola, D. M., Omary, M. B., The cytoskeleton of digestive epithelia in health and disease. Am. J. Physiol. 1999, 277, G1108-G1137.
43. Xu, G. M., Sikaneta, T., Sullivan, B. M., Zhang, Q. et al., Polycystin-1 interacts with intermediate filaments. J. Biol. Chem. 2001, 276, 46544-46552.
44. Houle, F., Poirier, A., Dumaresq, J., Huot, J., DAP kinase mediates the phosphorylation of tropomyosin-1 down-stream of the ERK pathway, which regulates the formation of stress fibers in response to oxidative stress. J. Cell Sci. 2007, 120, 3666-3677.
45. Houle, F., Rousseau, S., Morrice, N., Luc, M. et al., Extra-cellular signal-regulated kinase mediates phosphorylation of tropomyosin-1 to promote cytoskeleton remodeling in response to oxidative stress: impact on membrane blebbing. Mol. Biol. Cell 2003, 14, 1418-1432.
46. Li, Q., Dai, Y., Guo, L, Liu, Y. et al., Polycystin-2 associates with tropomyosin-1, an actin microfilament component. J. Mol. Biol. 2003, 325, 949-962.
47. Ogborn, M. R., Nitschmann, E., Bankovic-Calic, N., Buist, R., Peeling, J., The effect of dietary flaxseed supplementation on organic anion and osmolyte content and excretion in rat polycystic kidney disease. Biochem. Cell Biol. 1998, 76, 553-559.
48. Maser, R. L., Vassmer, D., Magenheimer, B. S., Calvet, J. P., Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease. J. Am. Soc. Nephrol. 2002, 13, 991-999.
49. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., Korsmeyer, S. J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75, 241-251.
50. Hochman, A., Liang, H., Offen, D., Melamed, E., Sternin, H., Developmental changes in antioxidant enzymes and oxidative damage in kidneys, liver and brain of bcl-2 knockout mice. Cell Mol. Biol. 2000, 46, 41-52.